Skip to main content
. 2021 Jul 12;8:690436. doi: 10.3389/fsurg.2021.690436

Table 2.

Baseline variables analyzed.

DF group
(n: 20)
D group
(n: 35)
P-value
Recipient data
Age (years), mean ± SE 59.6 ± 2.2 61.4 ± 1.8 0.54
Male, n (%) 9 (45) 24 (68.6) 0.09
BMI (kg/m2), mean ± SE 26.3 ± 1.2 27 ± 0.8 0.63
Race, n (%)
Afro-American 2 (10) 6 (17.1) 0.47
Hispanic 14 (70) 17 (48.6) 0.12
Caucasian 4 (20) 12 (34.3) 0.26
MELD score, mean ± SE 27.7 ± 1.4 29.2 ± 1.1 0.41
DM, n (%) 10 (50) 26 (74.3) 0.07
ESRD etiology, n (%)
HRS 5 (25) 17 (48.6) 0.09
Metabolic (DM and/or HTN) 7 (35) 22 (62.9) 0.05
PKD 5 (25) 2 (5.7) 0.04
Glomerulonephritis 2 (10) 1 (2.9) 0.26
Othera 4 (20) 9 (25.7) 0.63
Timing of kidney failure, n (%)
AKI 3 (15) 6 (17.1) 0.84
AKI on CKI 2 (10) 11 (31.4) 0.07
CKI 15 (75) 18 (51.4) 0.09
Dialysis modality
Pre-emptive, n (%) 5 (25) 9 (25.7) 0.95
Hemodialysis, n (%) 15 (75) 26 (74.3) 0.95
Pre-transplant CVVH, n (%) 4 (20) 5 (14.3) 0.58
Liver re-transplant, n (%) 0 (0) 5 (14.3) 0.08
Kidney re-transplant, n (%) 0 (0) 1 (2.9) 0.45
Serum Albumin (g/dL), mean*/SE 3.69*/1.05 3.05*/1.04 0.006
Platelet count (per ml), mean*/SE 79.6*/1.2 55.7*/1.1 0.14
INR value, mean*/SE 1.36*/1.07 1.64*/1.06 0.04
Donor data
Age (years), mean ± SE 36.4 ± 3.5 40.2 ± 2.4 0.36
BMI (kg/m2), mean ± SE 25.5 ± 1.1 25.5 ± 0.8 0.99
DCD, n (%) 4 (20) 6 (17.1) 0.79
KDPI (%), mean ± SE 41.6 ± 5.7 42.2 ± 3.9 0.93
Kidney transplant data
Delayed KTx, n (%) 14 (35) 26 (65) 0.73
CIT (h), mean ± SE 18.5 ± 2.2 27.3 ± 2.2 0.01
WIT (min), mean ± SE 28.1 ± 1.6 30.8 ± 1.3 0.21
Placement of ureteral stent, n (%) 0 (0) 4 (11.4) 0.12
a

Calcineurin Inhibitor Toxicity, Focal Segmental Glomerulosclerosis, HCV or HIV nephropathy.

BMI, Body Mass Index; MELD, Model for End-stage Liver Disease; DM, Diabetes Mellitus; ESRD, End-Stage Renal Disease; HRS, Hepato-Renal Syndrome; HTN, Hypertension; PKD, Polycystic Kidney Disease; AKI, Acute Kidney Injury; CKI, Chronic Kidney Injury; CVVH, Continuous Venous-Venous Hemofiltration; DCD, Donation after Cardiac Death; KDPI, Kidney Donor Profile Index; CIT, Cold Ischemic Time; WIT, Warm Ischemic Time.

HHS Vulnerability Disclosure